Finemedix Co., Ltd. (KOSDAQ:387570)
7,390.00
+90.00 (1.23%)
At close: Jan 29, 2026
Finemedix Revenue
Finemedix had revenue of 2.20B KRW in the quarter ending September 30, 2025, a decrease of -4.89%. This brings the company's revenue in the last twelve months to 10.48B, up 12.92% year-over-year. In the year 2024, Finemedix had annual revenue of 9.96B, down -1.91%.
Revenue (ttm)
10.48B
Revenue Growth
+12.92%
P/S Ratio
3.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
40.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.96B | -193.73M | -1.91% |
| Dec 31, 2023 | 10.15B | 2.01B | 24.71% |
| Dec 31, 2022 | 8.14B | 888.41M | 12.25% |
| Dec 31, 2021 | 7.25B | -656.61M | -8.30% |
| Dec 31, 2020 | 7.91B | 299.80M | 3.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 117.11B |
| Synergy Innovation | 106.25B |
| Corentec | 106.14B |
| M.I.TECH Co.,Ltd | 40.20B |
| BIOBIJOU | 33.71B |
| Sanigen Co. | 27.30B |
| Alpha AI | 25.98B |
| Genolution | 9.15B |